New insight could change the way physicians treat disorders like insomnia.
intestines © ag visuell - stock.adobe.com
Sleep-related phenotypes (SRPs) have been associated with individual gut microbiomes, laying the foundation for novel insights into insomnia disorders, according to a recent study published in Frontiers in Microbiology.
Sleep disturbances such as shortened sleep duration, disruptive snoring, easy arousal, early awakening, challenges falling asleep as well as combatting daytime drowsiness have taken a growing toll on public health in a post-COVID world. A lack of quality sleep has been linked to a variety of health issues including increased risk for diabetes and cardiovascular problems, challenges with weight, weakened immune system, higher blood pressure, and more.
At present, insomnia disorders are approached with certain medications or sleep cognitive-behavioral therapy—both of which have drawbacks that may not resolve the underlying issues, such as psychological dependence and risk of discontinuation, among others. These insufficient solutions and the burdens insomnia places on individual health highlight the importance of expanding clinical knowledge on the pathophysiology, identifying risk factors, and creating better prevention and therapeutic methods to combat sleep disorders.
The gut microbiota (GM) has indicated in insomnia, largely through its relationship with brain function via the brain-gut microbiota axis (BGMA). While insomnia is a complicated condition that can be influenced by circadian rhythm, mental health, one’s sleep environment, diet habits, and more, the authors of the present study note that Lachnospira, Bacteroides, Faecalibacterium and Blautia have been identified as bacteria that distinguish degrees of insomnia in patients from otherwise healthy controls.
Yet, studies in this area have not produced strong enough evidence to correlate the GM with sleep characteristics because something like insomnia is easily influenced by a myriad of confounding factors. To mitigate this impact, researchers conducted a bidirectional Mendelian randomization (MR) to explore this relationship because this form of analysis is less affected by individual lifestyles or environmental factors and has been utilized in other studies concerned with the GM.
Data were gathered from the MiBioGen alliance, which houses information on 18,340 individuals. In their taxonomic classification, researchers identified 131 genera and 196 bacterial taxa to be analyzed. SRP traits of interest included chronotype (morning or evening preference), insomnia, sleep duration, daytime napping, morning wakefulness, and snoring.
A range of 6 to 12 casual associations were observed between risk of developing daytime drowsiness, early awakening, insomnia, one’s chronotype, daytime napping, sleep duration, and snoring with genera of the GM or changes in GM.
A Bonferroni-corrected test was also conducted and demonstrated that an increased proportion of class Negativicutes and order Selenomonadales were significantly linked to severe insomnia (OR, 1.03; 95% CI, 1.02-1.05; P = .0001). Additionally, results showed that increased levels of phylum Lentisphaerae was significantly linked to a longer duration of sleep (OR, 1.02; 95% CI, 1.01-1.04; P = .0005) and genus Senegalimassilia exposure significantly improved snoring symptoms (OR, 0.98; 95% CI, 0.96-0.99; P = .0001).
As the authors reflect on their findings, they emphasize the value of these results for the future of patient care. While more research is necessary to tease out the most effective intervention strategies to approach patient variability, their study can serve as a reference for how modulating the GM can potentially mitigate the risks, development, and severity of insomnia. These approaches, which could include probiotic supplementation, alterations to diet, or other analogous modalities, provide a significant stepping stone for the clinical management of insomnia and, in turn, the consequential health impacts.
This article originally appeared in AJMC.
Reference
Wang X, Wang C, Liu K, Wan Q, Wu W, Liu C. Association between sleep-related phenotypes and gut microbiota: a two-sample bidirectional Mendelian randomization study. Front Microbiol. 2024;15:1341643. doi: 10.3389/fmicb.2024.1341643
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
Dupixent Is Linked to a Higher Risk of Psoriasis in Patients With Atopic Dermatitis
July 8th 2025AD and psoriasis were once thought to be opposites in terms of immune response, with AD linked to a Th2-dominant pathway and psoriasis driven by Th17 inflammation. However, newer research has shown that these diseases can overlap in patients and may even share common pathways.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Autoimmune Diseases Almost Double Mental Health Disorder Risk
July 7th 2025The prevalence of autoimmune disease patients with a mental health disorder is almost twice the number of patients without, suggesting there is a link between inflammation and conditions such as depression, anxiety disorder and bipolar disorder.
Read More